$89.23
-0.59-0.66%
Dern. MÀJ: Oct 13, 10:20 AM
Rhythm Pharmaceuticals (RYTM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
fiscal year (2024) a publié ses dernières prévisions le $130M - $130M pour Rhythm Pharmaceuticals {{epsDirection}}. La société a prévu un chiffre d'affaires compris entre {{epsPriorRange}} et {{revenueDirection}} pour la période.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.84 | $-0.86 | $-0.78 | $-0.72 |
| Actual | $-0.73 | $-0.83 | $-0.73 | $-0.82 |
| Surprise | +13.1% | +3.49% | +6.41% | -13.9% |
| Revenue | ||||
| Estimate | $67.2M | $56.2M | $55.8M | $50.5M |
| Actual | $71.3M | $60.1M | $57.3M | $51.3M |
| Surprise | +6.04% | +7.05% | +2.52% | +1.61% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.74 | $-0.72 | $-0.41 | $-0.04 |
| Revenue | ||||
| Consensus | $84.3M | $99.1M | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-0.73 | $-0.84 | 13.1 % |
| Q1 | May 5, 2026 | $-0.83 | $-0.86 | 3.49 % |
| Q4 | Feb 26, 2026 | $-0.73 | $-0.78 | 6.41 % |
| Q3 | Nov 4, 2025 | $-0.82 | $-0.72 | -13.9 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $71.26M | $67.20M | 6.04 % |
| Q1 | May 5, 2026 | $60.11M | $56.16M | 7.05 % |
| Q4 | Feb 26, 2026 | $57.25M | $55.85M | 2.52 % |
| Q3 | Nov 4, 2025 | $51.30M | $50.48M | 1.61 % |